Form D · Other Health Care

Nia Therapeutics, Inc.

Allston, MA · CIK 0001758725

Offering snapshot reported Jun 3, 2026 · SEC filing

Reported sold
$23.6M
Offering amount: $26.5M
Investors reported
37
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Dec 22, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$11.8M$23.6MDec 30, 2021: $2,000,002.00Dec 30, 2021Dec 23, 2022: $6,224,956.00Dec 19, 2023: $6,324,949.00Feb 20, 2024: $8,543,906.00Nov 25, 2024: $10,405,542.00Jul 17, 2025: $15,637,194.00Mar 6, 2026: $18,843,973.00Jun 3, 2026: $23,573,844.00Jun 3, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$18,843,973 → $23,573,844
  • Reported investors33 → 37

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 3, 2026Amendment$23,573,844$4,729,871vs Mar 6, 202637SEC filing
Mar 6, 2026Amendment$18,843,973$3,206,779vs Jul 17, 202533SEC filing
Jul 17, 2025Amendment$15,637,194$5,231,652vs Nov 25, 202428SEC filing
Nov 25, 2024Amendment$10,405,542$1,861,636vs Feb 20, 202425SEC filing
Feb 20, 2024AmendmentYet to sellNo comparison0SEC filing
Feb 20, 2024Amendment$8,543,906$2,218,957vs Dec 19, 202324SEC filing
Feb 14, 2024Initial$8,543,906No comparison24SEC filing
Dec 19, 2023Amendment$6,324,949$99,993vs Dec 23, 202218SEC filing
Dec 23, 2022Amendment$6,224,956$4,224,954vs Dec 30, 202117SEC filing
Dec 30, 2021Initial$2,000,002No comparison4SEC filing
Sep 4, 2020Initial$1,500,000No comparison3SEC filing
Sep 12, 2019Initial$200,000No comparison1SEC filing
Nov 13, 2018Initial$850,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-427292

Source: Form D, filed Jun 3, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Larry Greenberg Director
Michael Kahana Director, Executive
Milton Morris Director
Daniel Rizzuto Director, Executive
Daniil Utin Executive
Daniel Utin Executive
Jonathan Wachter Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
119 Braintree St. Unit 703
Allston, MA, 02134